225 related articles for article (PubMed ID: 28411257)
1. Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.
Lazenka MF; Freitas KC; Henck S; Negus SS
J Pharmacol Exp Ther; 2017 Jul; 362(1):14-23. PubMed ID: 28411257
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects of dopamine D1- and D2-like agonists on intracranial self-stimulation in male rats.
Lazenka MF; Legakis LP; Negus SS
Exp Clin Psychopharmacol; 2016 Jun; 24(3):193-205. PubMed ID: 26987070
[TBL] [Abstract][Full Text] [Related]
3. Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.
Freitas KC; Carroll FI; Negus SS
J Pharmacol Exp Ther; 2015 Nov; 355(2):341-50. PubMed ID: 26359313
[TBL] [Abstract][Full Text] [Related]
4. Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.
Altarifi AA; Rice KC; Negus SS
J Pharmacol Exp Ther; 2015 Feb; 352(2):208-17. PubMed ID: 25406170
[TBL] [Abstract][Full Text] [Related]
5. Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.
Kwilasz AJ; Negus SS
J Pharmacol Exp Ther; 2012 Nov; 343(2):389-400. PubMed ID: 22892341
[TBL] [Abstract][Full Text] [Related]
6. Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.
Negus SS; Rosenberg MB; Altarifi AA; O'Connell RH; Folk JE; Rice KC
J Pain; 2012 Apr; 13(4):317-27. PubMed ID: 22424913
[TBL] [Abstract][Full Text] [Related]
7. Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.
Rosenberg MB; Carroll FI; Negus SS
J Pain; 2013 Mar; 14(3):246-59. PubMed ID: 23332494
[TBL] [Abstract][Full Text] [Related]
8. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.
Negus SS; Morrissey EM; Rosenberg M; Cheng K; Rice KC
Psychopharmacology (Berl); 2010 Jun; 210(2):149-59. PubMed ID: 20101391
[TBL] [Abstract][Full Text] [Related]
9. Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.
Legakis LP; Karim-Nejad L; Negus SS
Psychopharmacology (Berl); 2020 Jul; 237(7):2201-2212. PubMed ID: 32382785
[TBL] [Abstract][Full Text] [Related]
10. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
Kwilasz AJ; Abdullah RA; Poklis JL; Lichtman AH; Negus SS
Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
Barrett AC; Miller JR; Dohrmann JM; Caine SB
Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
[TBL] [Abstract][Full Text] [Related]
12. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior.
Pereira Do Carmo G; Stevenson GW; Carlezon WA; Negus SS
Pain; 2009 Jul; 144(1-2):170-7. PubMed ID: 19435650
[TBL] [Abstract][Full Text] [Related]
13. Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.
Altarifi AA; Negus SS
Eur J Pharmacol; 2015 Feb; 748():76-82. PubMed ID: 25530266
[TBL] [Abstract][Full Text] [Related]
14. Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.
Hillhouse TM; Negus SS
Eur J Pain; 2016 Sep; 20(8):1229-40. PubMed ID: 26914635
[TBL] [Abstract][Full Text] [Related]
15. Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids.
Leitl MD; Onvani S; Bowers MS; Cheng K; Rice KC; Carlezon WA; Banks ML; Negus SS
Neuropsychopharmacology; 2014 Feb; 39(3):614-24. PubMed ID: 24008352
[TBL] [Abstract][Full Text] [Related]
16. Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats.
Miller LL; Leitl MD; Banks ML; Blough BE; Negus SS
Pain; 2015 Jan; 156(1):175-184. PubMed ID: 25599313
[TBL] [Abstract][Full Text] [Related]
17. Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.
Lazenka ML; Moerke MJ; Townsend EA; Freeman KB; Carroll FI; Negus SS
Psychopharmacology (Berl); 2018 Jan; 235(1):203-213. PubMed ID: 29063139
[TBL] [Abstract][Full Text] [Related]
18. A dopamine D1 agonist elevates self-stimulation thresholds: comparison to other dopamine-selective drugs.
Baldo BA; Jain K; Veraldi L; Koob GF; Markou A
Pharmacol Biochem Behav; 1999 Apr; 62(4):659-72. PubMed ID: 10208371
[TBL] [Abstract][Full Text] [Related]
19. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
Katz JL; Kopajtic TA; Terry P
Behav Pharmacol; 2006 Jun; 17(4):303-9. PubMed ID: 16914948
[TBL] [Abstract][Full Text] [Related]
20. Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam.
Moerke MJ; Li G; Golani LK; Cook J; Negus SS
Behav Pharmacol; 2019 Aug; 30(5):452-461. PubMed ID: 30640180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
